$59.03
0.75% yesterday
NYSE, Aug 12, 10:00 pm CET
ISIN
US2546041011
Symbol
IRON

Disc Medicine Stock price

$59.03
+1.29 2.23% 1M
+5.39 10.05% 6M
-4.37 6.89% YTD
+14.01 31.12% 1Y
+41.43 235.40% 3Y
-43.97 42.69% 5Y
-43.97 42.69% 10Y
-43.97 42.69% 20Y
NYSE, Closing price Tue, Aug 12 2025
+0.44 0.75%
ISIN
US2546041011
Symbol
IRON
Industry

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$1.4b
Net debt
positive
Cash
$694.7m
Shares outstanding
34.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
89.3%
Return on Equity
-24.6%
ROCE
-20.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-138.1m | $-195.3m
EBIT
$-138.2m | $-179.0m
Net Income
$-116.5m | $-165.8m
Free Cash Flow
$-103.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-41.8% | -50.8%
EBIT
-41.8% | -38.0%
Net Income
-44.5% | -51.6%
Free Cash Flow
-43.6%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.5
FCF per Share
$-3.0
Short interest
9.1%
Employees
84
Rev per Employee
$0.0
Show more

Is Disc Medicine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Disc Medicine Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Disc Medicine forecast:

18x Buy
95%
1x Hold
5%

Analyst Opinions

19 Analysts have issued a Disc Medicine forecast:

Buy
95%
Hold
5%

Financial data from Disc Medicine

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 37 37
52% 52%
-
- Research and Development Expense 101 101
38% 38%
-
-138 -138
42% 42%
-
- Depreciation and Amortization 0.15 0.15
50% 50%
-
EBIT (Operating Income) EBIT -138 -138
42% 42%
-
Net Profit -116 -116
45% 45%
-

In millions USD.

Don't miss a Thing! We will send you all news about Disc Medicine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.

Head office United States
CEO John Quisel
Employees 84
Founded 2017
Website www.discmedicine.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today